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ABSTRACT 
Background: In recent research, links have been found between androgens and anabolic body 
composition. Some findings suggest that androgen hormones in female athletes are positively 
associated with both power and aerobic performance, while other studies have found that 
body composition is associated with aerobic performance. The study is intended to investigate 
the association between circulating androgen levels, body composition, and physical 
performance in female athletes. 
Methods: This research consists of a cross-sectional study of 34 high-level Norwegian female 
athletes aged between 18 and 34 years (mean 22 years). The participants consisted of 25 
soccer players and 9 cross-country skiers. For physical performance examinations, VO2 max 
tests on treadmill were conducted, and squat jumps on a power platform. Lactate 
concentration after VO2 max test was also measured. Bloods samples were drawn after an 
overnight fast. Free testosterone index (FTI) was used as androgen variable in the analyses. 
DEXA scans were used to estimate body composition. 
Results: The analyses did not show statistically significant associations between FTI and 
body composition, or between FTI and physical performances. Some significant associations 
were found between the body composition variables and the physical performance measures. 
The soccer players and cross-country skiers were similar to each other in terms of androgen 
levels, age, height, and lean body mass (LBM), but statistically significant differences were 
found in fat percentage, weight, body mass index (BMI), and performance on squat jump 
power and VO2 max. Compared to cross-country skiers soccer players developed significantly 
more power in the squat jump (p = 0.01), but not in squat jump height (p = 0.21) while cross-
country skiers performed better on VO2 max test (p<0.001). Fat percentage was negatively 
associated with squat jump height in soccer players (β = -0.551, p = 0.016). In regression 
analyses fat percentage and LBM were negatively associated with oxygen consumption in 
cross-country skiers (β -1.144, p = 0.043 and β -1.251, p = 0.045). 
Conclusion: The most important finding in this research is that androgen levels, given by 
FTI, are not associated with either body composition or physical performance. This 
contradicts previous research. The statistically significant associations found among the 
participants were related to sport discipline and body composition.  
  
Keywords: Female athletes, circulating androgens, physical performance, body composition.  
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PREFACE 
This master’s thesis is part of a larger, ongoing research program, on female athletes. The 
focus in the research program is the association between hormone levels, physical capacity 
and wellbeing of the athletes. The research program will examine the possible associations 
between androgens and lean body mass, fat mass, bone mass density, and gynecological 
health. Mental health, eating attitudes and competitiveness is also part of the research 
program. In this thesis only data from limited hormone analyses, physical performance, and 
parts of body composition will be used. The data collection for this thesis ended February 
2012. At that time 36 athletes had participated in the different tests and measurements. 
Several departments from the Norwegian University of Science and Technology 
(NTNU) are involved in the research program: Unit for Applied Clinical Research at 
Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Department of 
Psychology, and Department of Human Movement Science, Faculty of Social Science and 
Technology Management. In addition, Department of Endocrinology and Department of 
Obstetrics and Gynecology, St. Olavs Hospital is involved. Olympiatoppen Mid-Norway has 
assisted in the recruitment process and under physical examinations of the subjects. 
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TERMS AND ABBREVATIONS   
The following terms and abbreviations will be used in this thesis: 
 Androgens: Steroid hormones that control the development and maintenance of 
masculine characteristics. 
 BMD: Bone mineral density (g/cm2). 
 Circulating androgen levels: Refers to androgen levels in the blood. 
 DHEAS: Dehydroepiandrosterone sulphate. 
 FTI: Free testosterone index. Calculated independent of unit of measurement: FTI= 
(testosterone/SHBG) × 10. FTI is considered to be a measure of free testosterone in 
the circulation, i.e. testosterone that are biologically active and exert testosterone 
effects.  
 Hyperandrogenism: The state of having increased androgen levels. 
 Hypoestrogenism: The state of having reduced estrogen levels. 
 LBM: Lean body mass. 
 MDs: Menstrual disturbances. 
 Oligomenorrhoea: Menstrual periods > 35 days apart, with only four to nine periods 
in a year.  
 PCOS: Polycystic ovary syndrome. 
 Secondary amenorrhoea: Absence of menstruation for at least 6 months after a 
period with menstruation. 
 SHBG: Sex hormone-binding globulin. 
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INTRODUCTION 
 
Top level athletes are subject to extreme physical and psychological stress, and they are in 
continuous need of tailored training, diet, and general lifestyle adjustments for as long as they 
want to stay competitive and in good health. Different disciplines seem to foster certain body 
types making some females more eligible to develop the necessary physics and skills [1]. An 
individual’s ability to succeed in top athletics depends on factors such as motivation, 
nutrition, training, environment, and genetic inheritance [2-5]. Accordingly, only a small 
proportion of women become top-level professional athletes. 
However, being a top athlete is not necessarily in accordance with optimal health 
condition [6, 7]. Hard physical exercise, in combination with caloric deficiency, may result in 
reduced fat mass, which may lead to menstrual and reproductive dysfunction and 
hypoestrogenism. This may in turn lead to reduced bone mineral density (BMD) and other 
health problems. Contrary to these catabolic outcomes, competitive sport is also able to 
induce anabolic effects for some athletes, by gaining more muscular volume and increased 
BMD [8]. Several findings indicate that androgens, i.e. male sex hormones, are positively 
correlated to lean body mass (LBM), and have an enhancing effect on physical performance 
[6, 9, 10]. Findings have even suggested that a state of increased androgen levels may play a 
role when young female athletes choose to participate in sport [11].  
Extended information on the association between female athletes’ hormone levels and 
physical performance is needed [12]. With increased knowledge one may improve abilities to 
customize the most ideal training and diet for each individual, to achieve best performance 
results and ensure the athletes’ health conditions, both during the years they compete and 
thereafter.  
The aim of the study is to investigate the association between circulating androgen 
levels, body composition, and physical performance in a sample of Norwegian soccer players 
and cross-country skiers.  
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Hormone Levels 
Several studies using different physical tests show that some of the best performing female 
athletes tend to have sex hormones levels that differs from average female values [6, 9, 10]. 
Immediately after both resistance and endurance exercise findings show that training can 
induce androgen level alternations in both sexes, by increasing hormones like testosterone, 
androstenedione, and dehydropiandrosterone sulphate (DHEAS) [13]. According to Enea et 
al. the endocrine system is significantly stimulated by physical exercise, with remarkable 
effects on female physiology. Significantly developed musculature in females may in part 
derive from hyperandrogenism, while chronic state of energy deficiency in female athletes 
may lead to hypoestrogenism [14]. Imbalanced male and female sex hormone levels in female 
athletes are often expressed by menstrual disturbances (MDs) the years they exercise to 
compete [6, 12, 15-18].  
Rickenlund et al. [6] found that hyperandrogenic female athletes had menarche 
approximately two years later (15.8 vs. 13.8 years) than normoandrogenic female athletes, 
indicating that there is an initial difference, prior to the years of hard training. Eliakim [11] 
suggested that hyperandrogenism in a young female athlete may influence the selection to 
participate and perform in sport. Findings indicate that there are critical periods during 
intrauterine life where increased androgen levels influence the fetus’ hormonal balance more, 
with lifelong effects [19, 20]. Irrespective of cause and effect, it is known that longstanding 
hyperandrogenism and anovulation are associated with polycystic ovary syndrome (PCOS), 
and accompanying metabolic and reproductive complications [6, 21].  
Hagmar et al. [8] studied 90 female Olympic athletes from 27 various disciplines, and 
found that 13 % of power athletes and 66 % of endurance athletes had MDs. A Norwegian 
survey  of 1276 elite female athletes and controls suggest that it is not training volume, but 
participation in leanness sports that associates with menstrual dysfunction [22] . In 
Drinkwater et al.’s sample mean running distance per week (67.3 km vs. 41.8 km), but not 
caloric intake, differed substantially between athletes with and without MDs [17]. The 
investigators also detected estradiol levels approximately 50 % lower in the athletes with 
MDs, suggesting hypoestrogenic status. MDs in endurance sport athletes are more extensively 
reported compared to power sport athletes, though this may be subject to publication bias, as 
this relationship tends to be investigated more for endurance athletes. 
If MDs are unrelated to energy intakes, they appear to be more typical for power and 
strength sports. In Hagmar et al.’s study [8] most MDs were due to hyperandrogenism. They 
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detected polycystic ovaries, which is one out of three criteria for PCOS diagnosis, in 37 % of 
females in their sample not using hormonal contraception and 12.5 % among users. Among 
the participants with polycystic ovaries 42 % were power athletes, 33 % endurance athletes, 
and 22 % technical athletes.  
 
Body Composition  
As results from discipline-specific training and the athlete’s biological basis, the distribution 
between lean and muscular athletes, vary between disciplines [2, 23, 24]. Endurance sports 
suggest a more marked aerobic metabolism where low body fat is more important than muscle 
strength [7]. Tomten et al [15] found a linearly associated relationship between MDs and 
lowering of BMD in Norwegian female runners. One of the most important hormonal factors 
involved in bone health is estradiol [14]. Estradiol is an estrogen, which like all other steroids 
is derived from cholesterol [25]. 
Strength and power sport athletes are known to  possess higher BMD, LBM and 
upper-lower fat mass ratio [8]. Weight training can be similar to aerobic exercise in regards to 
achieving fat loss, and at the same time increase fat-free mass [26]. Milanese et al.’s study 
[27] comparing elite and sub-elite handball players showed higher bone mineral content lower 
fat percentage and a clear tendency to accrue more LBM, especially in upper limbs, in elite 
handball players. 
Hickey et al. [28] found a positive linear relationship between FTI and increasing 
weight in a sample of 244 unselected post-menarchal adolescents. In a sample of 60 non-
athletes, the normal weight females with PCOS exhibited higher amounts of adipose tissue 
compared to healthy controls, and a tendency towards central obesity patterning, i.e. fat 
localized in trunk and upper body [29]. Other studies on both athlete and non-athlete females, 
have found that hyperandrogenic women have higher BMI, LBM, waist circumference, and 
percentage of body fat compared to normoandrogenic athletes with MDs, healthy athletes, and 
sedentary controls, even when similar dietary habits are reported [6, 30]. Neassen [31] state 
that androgens have appetite-increasing effects. These findings may indicate that 
hyperandrogenic women may have more difficulties maintaining a slim body and might 
thereby be less suitable for lean-weight sports. Furthermore, the relationship between 
cholesterol, estradiol and BMD mentioned above may explain why hyperandrogenic females 
are prevented against low BMD. 
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Physical Performance 
Several findings indicate that there are positive associations between androgens and the 
amount of muscle mass, and that androgens enhance physical performance [6, 9, 10]. 
Cardinale et al. [9] found a significant positive relationship between testosterone levels and 
countermovement jump in male and female elite athletes. Rickenlund et al.’s study [6] support 
this finding, as females with the highest androgen levels had significantly higher isometric leg 
strength, and the highest maximal oxygen uptake. Numerically higher values for blood lactate 
concentration were found for hyperandrogenic females, possibly due to longer running 
duration. An alternative explanation may be that hyperandrogenic athletes are more motivated 
and able to push themselves more in tests. No differences were found in perceived dypsnea-
exertion indicating that hyperandrogenic females are able to provide more effort without 
feeling more exhausted. Interestingly, Rickenlund et al. found no differences between 
normoandrogenic and hyperandrogenic women in hand grip muscle strength, and interpret 
this finding  as an indication that the hyperandrogenic females may have performed better due 
to task-specific training condition, and not because of their androgen levels alone [6]. 
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METHOD 
 
DESIGN 
This is a cross-sectional study of female soccer players and cross country skiing athletes.  
 
SUBJECTS   
The study sample consists of 34 female athletes aged between 18 and 34 years (mean age 22 
years), all Caucasian. Due to incomplete data two athletes were excluded, reducing the sample 
size from 36 to 34. Of these, 25 were soccer players from two different teams, and nine were 
cross-country skiers. The participants were under supervision of Olympiatoppen Mid-
Norway, competing at high level in soccer or cross-country skiing. Athletes that were injured, 
pregnant, or breast feeding, were excluded from participation in the study in order to avoid 
potentially misleading values. All subjects reported feeling well on the day when the tests 
were performed.  
 
PROCEDURES 
Subjects were recruited between September 2011 and February 2012, an information letter 
and declaration of consent can be found in appendix 1 and 2, respectively. 
Testing started in December 2011 and was completed in February 2012. The subjects 
visited Department of Human Movement Science, Dragvoll, NTNU, for physical performance 
tests at one occasion, at their preferred time. Further, they had a DEXA scan and a 
gynecological examination at St. Olavs Hospital, Trondheim University Hospital. Blood 
samples were drawn in the fasting state between 08 and 10 am, preferentially within 3 days of 
the physical testing. There was little exchange in test personnel to ensure consistency in 
instructions and implementation method during testing throughout the study. The test 
personnel conducting the physical performance tests were master students, performing power 
tests, and two employees from Olympiatoppen Mid-Norway, performing aerobic capacity 
tests. All data was stored for offline analysis. 
 
6 
 
MEASUREMENTS 
Anthropometric Data 
Measurements were performed at Department of Human Movement Science at Dragvoll, 
NTNU. Height and weight were measured. Height (to the nearest centimeter) was measured 
without shoes, and weight was measured while the subjects wore light-weight training 
clothes. 
 
Physical Examinations of Performance 
There were three physical performance examinations of each subject, of which two is 
included in the scope of this thesis; maximal power in lower body (squat jump height), and 
oxygen consumption (average last minute VO2). 
Maximal muscular power in the lower body was assessed by explosive power in a 
squat jump performed on AMTI Biomechanics Force Platform
1
. The subject was instructed to 
hold their hands on the hips and start in a freely chosen squat depth where they felt most 
capable of producing the highest possible squat jump. We recorded until each subject had 
delivered 3 approved trials, i.e. a jump with both arms attached to the hips, without any 
countermovement registered. Jump height, maximal power, rate of force development and 
time to peak power was calculated from the Biojump force plate
2
, and used to determine 
maximal muscular power. The focus of interest here is the actual jump performance in 
centimeters and therefore this was used in the analyses. 
Aerobic capacity was measured by VO2 max test on a treadmill. The subject warmed 
up for approximately 15 min on around 60 % of maximal heart rate. Test duration lasted 
between 5-8 minutes for most of the athletes (minimum 4, maximum 11.20), performed on 
10.5 % incline with stepwise speed increase by 1 km/h every minute. VO2 was measured 
through pulmonary gas exchange, using an Oxycon Pro
3
 throughout the test with a sample 
frequency of 0.1 Hz. The average of the six highest 10-s consecutive measurements 
determines VO2 max. Heart rate was measured continuously during the test and blood lactate 
was measured after completing the test using Lactate Pro
4
. The test was considered maximal 
effort when two of the following criteria are met: a plateau in VO2 with increasing intensity, 
                                                 
1
 Model bp6001200, Massachusetts, USA 
2
 Biojump program version 2.2, Oslo, Norway 
3
 Jaeger GmbH, Hoechberg, Germany 
4
 LT-1710, ArkRay Inc, Kyoto, Japan 
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respiratory exchange ratio (R-value) above 1.10, and blood lactate concentration exceeding 8 
mmol/L. In the analysis we called the oxygen consumption variable Last Minute VO2.  
 
Biochemical Hormone Analyses 
All of the nine cross-country skiers and 23 out of 25 soccer players participated in the 
hormone analyses. The participants were instructed to have an overnight fast before blood 
samples were drawn. Between 8 am and 10 am blood samples were drawn from an antecubital 
vein. For a maximum of 14 days serum was stored at -20 degrees centigrade. After this period 
serum was transmitted to a -80 degrees centigrade freezer. Organic solvent extractions 
(dichloromethane for testosterone and ethyl ether for androstenedione) were used 
before testosterone and androstenedione analyses. Androstenedione was measured with a 
competitive immunoassay based on the use of antibody-coated tubes, the Coat-A-Count® 
Direct Androstenedione procedure, using reagents and calibrators from Siemens
5
. Enzyme-
linked immunosorbent assay (ELISA) was used for quantitative determination in serum for 
measuring testosterone, DHEAS, SHBG, and 17-hydroxy-progesterone. Intra-assay 
coefficients of variation were 5.6 % for androstenedione, 9.5 % for testosterone, 2.8 % for 
DHEAS, 6.6 % for SHBG, and 1.8 % for 17-hydoxy-progesterone. In all estimations samples 
were measured in duplicates and the mean of the two measurements was used. Free 
testosterone index (FTI) is the focus variable in further analysis as it is considered the 
biologically active testosterone. FTI was calculated by the formula FTI = 
(testosterone/SHBG) × 10, where testosterone and SHBG are both measured in nmol/L.  
 
Dual-Energy X-ray Absorptiometry  
Dual-Energy X-ray Absorptiometry (DEXA) scan were performed with a Hologic Discovery 
A scanner
6
. Method of analysis was Whole Body Auto Fan Beam. This scan determines total 
fat mass and total lean mass in kilogram, in addition to total fat mass and total lean mass in 
percentage of total body mass.  
 
STATISTICS 
In the analysis the sample were separated into two groups. The characteristics of the sample 
                                                 
5
Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA 
6
 Version 12.7.3.1, Hologic, USA 
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were presented as frequencies and means in a descriptive analysis, with standard deviations 
(SD) and range. The two groups’ means were compared with Independent Sample t-test, 
statistical significance were set as p<0.05. Scatter plots illustrate the sample distributions in 
the different exercises. Bivariate Pearson’s correlation analysis was used to investigate the 
associations between the variables. Multivariate linear regression analyses were conducted, 
adjusting for all androgens, body composition and age, to evaluate whether any of these had 
confounding effects on the performances. All statistical analyses were two-sided. All analyses 
were conducted with SPSS version 19.0 for Windows
7
. 
 
ETHICS 
The project was approved by The Regional Ethical Committee in Mid-Norway (appendix 3). 
Participants were included in the study only after a declaration of consent was signed 
(appendix 2).  Results were anonymously stored and analyzed. Study participation was 
evaluated to involve minimal health risk. The Declaration of Helsinki was followed 
throughout the study. 
  
                                                 
7
 SPSS Inc., Chicago, Illinois, USA 
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RESULTS 
 
A total of 34 female athletes were included in the statistical analyses, all competing in high 
level soccer or cross-country skiing. The athletes were divided into two groups based on 
discipline, as shown in Table 1. The difference between the cross-country skiers and soccer 
players was not statistically significant in terms of age, height or LBM. However, they were 
significantly different from each other in terms of BMI, weight and body fat percentage.  
The t-test showed that squat jump results were higher on maximal power in soccer 
players, this difference was statistically significant, but it was not for jump height. Cross-
country skiers had significantly higher last minute VO2 and speed at the end of the test, and 
numerically lower lactate concentrations, compared to soccer players. There were no 
statistically significant differences in the measured hormones between the groups, but the 
soccer players had numerically higher values in androstenedione, testosterone, DHEAS, 17-
OH-progesterone, and FTI, and lower levels of SHBG compared to the skiers.  
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Table 1 - Descriptive statistics of the study participants 
Female athletes, total N=34 
 
Soccer player athletes 
N=25 
CC skiing athletes 
N=9 
t-test  
Variables Mean (SD) Range Mean (SD) Range t (df) p 
Age (years) 22.6 (3.7) 18-34 22.7 (2.9) 19-28 -0.02 (32) 0.985 
Height (cm) 167.8 (5.0) 161-178 168.3 (5.2) 161-176 -0.29 (32) 0.820 
Weight (kg) 63.3 (6.7) 52-76 58.4 (4.0) 54-66 2.27 (32) 0.030 
Body mass index (kg/m
2
)  22.3 (1.9) 19.5-25.3 20.5 (0.9) 19.1-22.3 2.77 (32) 0.009 
Lean body mass (kg) 48.6 (4.9) 40.3-58.1 47.7 (3.6) 42.0-51.7 0.48 (30) 0.635 
Total body fat percent (%) 20.5 (2.8) 14.4-24.1 15.8 (2.5) 12.5-19.1 4.29 (30) <0.000 
Physical performances 
Squat jump height (cm) 28.3 (4.8) 19.5-39.0 25.9 (4.5) 19.8-32.2 1.27 (32) 0.211 
Max power, squat jump (N)* 1320 (169.9) 1040-1658 1152 (109.3) 987-1394 2.74 (32) 0.010 
Last Minute VO2 (ml/kg/min) 53.3 (3.6) 46.3-60.4 63.3 (3.0) 59.3-66.9 -7.38 (31) <0.000 
Lactate (mmol) 11.2 (2.0) 5.7-14.7 9.9 (1.7) 8.0-13.4 1.59 (32) 0.121 
Speed at end of test (km/h) 11.1 (.8) 10-13 13.3 (.5) 13-14 -7.12 (29) <0.000 
R-value (CO2/O2) 1.13 (.04) 1.06-1.25 1.10 (.06) 0.99-1.19 1.86 (32) 0.072 
Hormone levels 
SHGB (mmol) 122 (74.2) 42-325 131 (45) 81-199 -0.32 (30) 0.748 
Testosterone (mmol/L) 1.36 (0.41) 0.6-2.2 1.17 (0.36) 0.6-1.76 1.21 (30) 0.238 
Androstenedione (mmol/L) 9.7 (2.9) 4.4-15.9 8.8 (2.9) 5.0-13.0 0.79 (30) 0.433 
DHEAS (µmol/L) 4.5 (1.7) 1.7-8.2 3.5 (1.1) 2.1-5.1 1.55 (30) 0.131 
FTI 0.16 (0.11) 0.03-0.47 0.10 (.05) 0.04-0.22 1.38 (30) 0.177 
N= total number of athletes included 
*Measured  in Newton 
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Scatter plots of the unadjusted associations between FTI and LBM, as well as the associations 
between FTI and fat percentage, are shown in Figure 1. None of the associations were 
statistical significant. Individual data and regression lines are shown for soccer players (heavy 
lines and filled dots) and cross-country skiers (grey line and open circles) in all of the 
following scatter plots.    
 
Unadjusted associations between FTI and performance on squat jump and VO2 max test in 
scatter plots are shown in Figure 2. None of the associations were statistically significant. 
 
  
Figure 1 - The correlation between FTI and LBM (left), and between FTI and fat percentage (right).  
  
Figure 2 - The correlations between FTI and squat jump height (left), and between FTI and last minute 
VO2 (right). 
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Figure 3 shows unadjusted correlation between fat percentage and physical performance. The 
only statistical significant correlation in this case, identified using Pearson’s analysis, is 
between fat percentage and squat jump height in soccer players (r = -0.502, p = 0.015). 
 
The Bivariate Pearson correlation analysis was conducted with all measured hormones 
included, both for the total group, and stratified with respect to sport discipline. According to 
these analyses there were no statistically significant correlations between FTI and physical 
performance, or between FTI and body composition. Correlations were found between body 
composition and performance, both in total and stratified sample. BMI and fat percent 
correlated inversely with last minute VO2 for total sample. More details can be found in 
appendix 4. 
Multivariate regression analyses for hormones, physical performance, and body 
composition were conducted both for total and stratified sample. Numeric results from the 
regression analyses are included in appendix 5. Due to co-linearity with FTI, testosterone and 
SHGB variables were excluded from this analysis. Since fat percentage and LBM co-varies 
with BMI, BMI was removed in all regression analyses. Table 2 below show the main 
findings from both correlation and regression analyses.  
  
Figure 3 - The unadjusted associations between fat percentage and squat jump height (left), and between fat 
percentage and last minute VO2 (right). 
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Table 2 – Summary of primary findings 
 FTI  
and body  
composition 
FTI  
and physical 
performance 
Body composition  
and physical  
performance 
Pearson 
correlations 
Total group: SS 
correlation between 
FTI and fat 
percentage. 
 
Soccer players: The 
SS correlation 
between FTI and fat 
percentage persisted. 
NS. Total group: SS correlations between 
BMI and sport discipline, and between 
fat percentage and sport discipline. 
 
Soccer players: SS correlation 
between fat percentage and squat 
jump height. 
Multivariate 
regression 
analyses 
NS. NS. Total group: SS association between  
fat percentage and sport discipline. 
 
Soccer players: SS association between 
fat percentage and squat jump height. 
 
Cross-country skiers: SS associations 
between last minute VO2 and LBM, and 
between last minute VO2 and fat 
percentage.  
Abbreviations: SS= statistically significant, NS= not statistically significant  
 
The multivariate regression analysis on squat jump height, adjusting for all hormones, 
body composition variables, and age showed no significant associations. However, when 
stratifying into sports group, there was a significant negative association between fat 
percentage and squat jump height in soccer players (β = -0.551, p = 0.016).  
Multivariate regression analysis on last minute VO2 of total sample, adjusted for all 
hormones, body composition variables, and age was also performed. Sport discipline was 
statistical significant associated with last minute VO2. When stratifying in sport groups, 
negative associations was found between last minute VO2 and LBM (β = -1.144, p = 0.043), 
as well as between last minute VO2 and fat percentage (β-1.251, p = 0.045) in cross-country 
skiers. 
In addition, multivariate analyses were conducted with the different body composition 
measures (fat percentage and LBM). None were significant using LBM as dependent variable. 
Sport discipline was statistically significant associated in multivariate regression analysis with 
fat percentage as dependent variable, adjusted for age, androgens, LBM and sport discipline.  
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DISCUSSION 
 
Among the athletes in this sample there were no statistically significant associations between 
FTI and any of the body composition variables, or between FTI and any of the physical 
performance exercises. This contradicts previous research [6, 9]. There were some significant 
associations between body composition and physical performance, but the associations were 
mainly related to fat percent and sport discipline.  
Previous research has shown that cytosine adenine guanine (CAG) repeat 
polymorphism within the androgen receptors, may determine the effectiveness of androgens 
[32]. Some studies claim that the length and number of androgen receptor CAG repeats, 
associates with PCOS [33, 34]. Skrgatic et al. [35] states that CAG repeat polymorphism in 
the androgen receptor gene is not directly associated with PCOS, but is a predictor for serum 
testosterone levels. This may partially explain the absence of associations in this study, as 
these components are not included.  
Details of the findings will be discussed in the following sections, while Appendix 4 
and 5 contains numeric details on the correlation and regression analyses. 
 
The Association between FTI and Body Composition 
There were no statistically significant associations between FTI and LBM, or between FTI 
and fat percentage among the athletes in this sample. However, Pearson correlations of total 
group show values relatively close to statistical significant between FTI and LBM. This 
tendency corresponds with other studies who have found associations between FTI and 
anabolic body composition [6, 8, 30]. In general these studies have a greater sample size than 
the present study. 
There were negative tendencies between FTI and fat percentage in our sample of 
cross-country skiers. The skiers’ fat percentages were relatively low, ranging between 12.5 – 
19.1 %, with a mean of 15.8 %. This is beneath previously recommended values for females 
in the general population. Frisch [36] claims that there is evidence that necessary body fat 
percentages for regular ovulatory cycles in mature women exceed 26 %. In contrast to this 
statement,  Loucks [37] state that ovulatory function depends more on energy balance than 
body fat mass, since menstrual function in some cases may regain long before an increase in 
body fat.  
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In this sample of soccer players FTI did not correlate with fat percentage. The mean 
BMI of 22.3 kg/m
2
 in our sample of soccer players is perfectly within normal range of 18.5-
24.99 kg/m
2
, as defined by World Health Organization [38]. From other studies on 
hyperandrogenism we see that this sample of soccer players, rather than cross-country skiers, 
have androgen levels most similar to those in hyperandrogenic females [6, 8]. These 
tendencies implies higher mean values on androstenedione, testosterone, DHEAS, 17-OH-
progesterone, and FTI, and lower on SHGB, in accordance with athletes with PCOS in 
Hagmar et al.’s study [8].  
If the tendencies persist in a larger study sample with statistical significant results, it 
may indicate that the relationship between FTI and fat percentage is influenced by training 
and sport discipline. An interesting question in this regard is whether it would indicate that 
FTI enhance the right exercise-specific body composition. Androgens are associated with 
motivational balance and risk-taking behavior [39]. Accordingly one may assume that 
androgens promote will to exert necessary efforts to succeed. In endurance sports like cross-
country skiing low fat is more important than high power, while soccer players are 
advantaged by versatile abilities as the sport demands certain levels of both explosive power 
and aerobic capacities [7, 40].  
 
The Association between FTI and Physical Performance  
Surprisingly, there were no statistical significant correlations between FTI and measured 
physical performance on either squat jump height or last minute VO2. 
These findings stand in contrast to a number of other studies who have found positive 
correlations between FTI and physical performance, both on power and aerobic capacity tests 
[6, 9, 10]. Storer et al. [10] states that testosterone correlates positively with maximal power, 
but does not affect fatigability. In Rickenlund et al.’s study [6] , hyperandrogenic females 
were performing better on VO2 max and Beep test, as well as having higher lactate 
concentrations compared to normoandrogen athletes with MDs and regular menstruating 
athletes. Thus, these hyperandrogenic female athletes show higher ability to perform during 
physical tests, despite of lactate accumulation, which may indicate more persistent will. This 
is in accordance with androgens and lactate concentrations measured in our sample of soccer 
players, being higher than those of cross-country skiers. However, it is expected that skiers 
perform better on aerobic capacity tests due to the nature of their sport. Number of training 
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sessions per week, years of training, and a number of other factors, may have more impact on 
physical performance than hormone levels [1, 5, 41, 42].  
 
The Association between Body Composition and Physical Performance 
When performing multivariate analyses with different body composition variables as 
dependent values, the statistically significant findings were related to sport discipline and fat 
percentage.  
It was expected that LBM would associate positively with performance on squat jump 
height. Multivariate regression analysis showed virtually no associations. When stratifying 
into sport groups, a statistical significant inverse correlation between fat percentage and squat 
jump height in soccer players was found. In this sample of soccer players, fat percentage 
generally seems to associate more with the physical exercises, than LBM and FTI. This seems 
logic as fat mass may act as extra load to carry when jumping or running. 
Stratified multivariate regression analysis of last minute VO2, adjusting for all 
variables, show that LBM tend to associate negatively in cross-country skiers. This was 
relatively close to statistical significant level. LBM may increase the load one has to carry 
while running, and accordingly more work must be done. The tendency of negative 
association between BMI and running performance in this study (appendix 5) matches 
findings from several other studies [42, 43]. Emphasizing other factors than the latter studies, 
a comparison study between novice and experienced marathon athletes suggest that improved 
performance is associated with higher aerobic capacity and years of training rather than with 
body dimensions [44]. Physical performance may depend more on factors like previous and 
current training amounts covered, lactate threshold, and genetics [5, 41]. The cross-country 
skiers exercise more specific to increase aerobic capacity, compared to soccer players. The 
fact that age associated positively with last minute VO 2 in this sample of cross-country skiers, 
but not soccer players, may confirm that oxygen consumption to a large degree depend on 
aerobic training amount covered.  
 
Strengths and Limitations of the Present Study 
This study has involved comprehensive measurements conducted on each participant. All 
biochemical measurements followed the normal biochemical procedures at St. Olavs Hospital. 
Though the two sport disciplines investigated are quite different, a denominator between them 
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is the fact that participation is related to performance capacities, not esthetic demands or 
weight classes. This results in a more comparable sample. 
Time and resource limitations resulted in a small sample of participants, and they 
represented only two sport disciplines. As noted earlier, this study marks the beginning of a 
larger research program, and was dependent on the number of available athletes at the time. 
With comparison groups outside elite sport one might have found hormonal differences 
between top athletes and females doing recreational physical activity or sedentary females. 
Further, it is possible that this study is subject to selection bias. The characteristics of the 
athletes that choose to participate could differ from the ones that ignored or rejected the 
invitation. 
 
Conclusion 
Results in this study indicated that associations between circulating androgen levels, physical 
performance, and body composition, are not statistically significant. Significant associations 
were related to sport discipline and body composition, rather than the free testosterone index. 
This contradicts findings in other reports [6, 8], but the latter research was based on more 
heterogeneous samples of athletes, including also technical and esthetic disciplines. The 
sample in this study is more homogenous, which may explain why some of the differences 
from previous studies were not confirmed in the present study.  
Stratified multivariate regression analyses yielded significant results related to body 
composition, basically showing that higher fat percentage has negative effect for jump 
performance in soccer players, and that both fat percentage and LBM are negative factors for 
VO2 max in cross-country skiers. These findings are intuitively reasonable. When comparing 
differences in body composition and physical performance between sport disciplines, it is 
reasonable to assume that type, amount, and intensity of training may influence more than 
hormone levels. However, these exercises measured in this study do not necessarily predict 
the athletes’ performance in the sport where they compete. 
Recommendations for further research include increased sample size in longitudinal 
studies and random clinical trials.  In addition athletes from different sport disciplines should 
be included, as well as comparison groups with lower physical activity levels. It is also 
important to study genetic and behavior factors’ effect on physical performance, body 
composition, and circulating androgens.  
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APPENDICES 
 
Appendix 1 – Information Letter 
 
Forespørsel om deltagelse i forskningsprosjekt:  
”The Female Competitiveness Study” – er det sammenheng mellom hormonnivåer og 
konkurranseinstinkt hos kvinnelige toppidrettsutøvere?  
 
Bakgrunn og hensikt  
Toppidrettsutøvere presser sin fysiske og psykiske kapasitet til det ytterste. De fysiske og 
psykiske aspektene og sammenhengen med hormonnivåer har vært studert tidligere, spesielt hos 
menn. Sammenhengen mellom hormonnivåer, fysisk kapasitet og mentale faktorer hos kvinner er 
derimot lite studert.  
Nivået av androgene hormoner (hormoner med testosteronvirkning) og spesielt testosteron er noe 
forhøyet hos kvinner med polycystisk ovarialsyndrom (PCOS). Kvinner med PCOS utgjør 10-15 
% av kvinner i fruktbar alder, de synes å ha høyere konkurranseinstinkt og delta mer i idrett enn 
kvinner uten PCOS. Det synes også å være en svak sammenheng mellom PCOS, 
humørsvingninger og spiseadferd. Vi tror mye av dette kan ha sammenheng med de noe økte 
nivåene av hormoner med testosteronvirkning og at kvinner med økte testosteronnivå i spesiell 
grad trekkes mot idrett generelt og toppidrett spesielt.  
Vi henvender oss til deg fordi du er en kvinnelig toppidrettsutøver for å be om ditt samtykke til 
deltakelse i dette forskningsprosjektet. Formålet med studien er å få økt kunnskap om 
sammenhengen mellom hormonnivåer hos kvinnelige toppidrettsutøvere og konkurranseinstinkt, 
muskelmasse, fysisk kapasitet, beintetthet, mentale forhold inkludert seksuell orientering og 
forekomsten av PCOS. Studien er et samarbeidsprosjekt mellom Avdeling for endokrinologi, St. 
Olavs hospital, Institutt for Bevegelsesvitenskap og Psykologisk Institutt, Norges teknisk- 
naturvitenskaplige universitet (NTNU) og Olympiatoppen Midt-Norge. Denne forespørselen går 
til toppidrettskvinner mellom 18 og 40.  
 
Hva innebærer deltagelse i studien?  
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Den enkelte deltager vil få utført en DEXA-scan og taking av fastende blodprøve ved Avdeling 
for endokrinologi, St. Olavs hospital. Ved DEXA-scan ligger man stille i truse på ryggen i 10 
minutter og det hele er helt smertefritt. Ved denne undersøkelsen bestemmes fettmasse, 
muskelmasse, beinmasse og beintetthet. I tillegg besvares spørreskjema om konkurranseinstinkt, 
spenningssøking, spiseadferd, mental helse og seksuell orientering. Vi vil også registrere 
resultatene fra fysiske tester (VO2 max, laktat, maksimal muskelkraft ved spensthopp og 
benkpress). Medisinbruk, spesielt hormonpreparater (p-pille, p-stav, p-sprøyte, hormonspiral etc.) 
vil bli registrert.  
I tillegg håper vi å kunne tilby en gynekologisk undersøkelse for deltagerne i studien.  
 
Mulige fordeler og ulemper  
Som deltager har du mulighet til å bidra til ny kunnskap om sammenhengen mellom forhold 
knyttet til idrettsprestasjoner og toppidrettskvinners helse. Deltagelse i prosjektet medfører testing 
og analyse av blant annet beintetthet og muskelmasse. Lav beintetthet og 
menstruasjonsforstyrrelser kan være et problem hos kvinner som trener mye. Dersom dette 
påvises kan fagpersonene i prosjektgruppen vurdere spesielle tiltak dersom du ønsker det.  
Opplever du noen av spørsmålene som ubehagelige er det greit å unnlate å besvare dem. Data vil 
uansett ikke kunne spores tilbake til enkeltpersoner etter at de er registrert i en database. Vi har 
dessverre ikke anledning til å gi deltagerne økonomisk kompensasjon så deltagere i prosjektet må 
selv dekke eventuelle reiseutgifter.  
Den fysiske testingen vil bli gjennomført etter standard prosedyrer for slik fysiologisk testing og 
risikoen for at noe kan skje er minimal. VO2 max kan oppleves som anstrengende, men gi nyttig 
informasjon som kan brukes til videre treningsplanlegging. Prestasjonstester vil også være 
standard og gjennomføres i tråd med trening du som utøver gjennomfører til daglig. Den eneste 
reelle forskjellen fra den daglige trening og testing er at dataene fra testene vil bli systematisert og 
lagret for brukt i prosjektet.  
 
Viktig! Dine forberedelser  
Blodprøvene vil bli tatt om morgenen, og du må faste 8 timer (dvs. fra midnatt) i forkant 
(inkludert røyk/snus-avhold). Dersom du er veldig tørst kan du evt. drikke et halvt glass vann 
morgenen før prøvene tas.  
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Hva skjer med testene og informasjonen om deg?  
Dine resultater fra undersøkelsene vil bli behandlet i ikke identifiserbar form, dvs. uten navn, 
fødselsnummer eller andre identifiserende opplysninger. En kode knytter deg til dine opplysninger 
og prøver, gjennom en navneliste. Denne koden oppbevares uavhengig av selve databasen med 
alle opplysningene fra studien. Det er kun autorisert helsepersonell knyttet til prosjektet som har 
adgang til navnelisten og som eventuelt kan finne tilbake til deg. Det vil ikke være mulig å 
identifisere deg i resultatene av studien når disse publiseres. Når prosjektet er avsluttet vil også 
koden som knytter deg til enkeltdata i databasen slettes.  
Dersom du ønsker det kan vi gi deg tilbakemelding på testresultatene (som for eksempel 
kroppssammensetning, VO2 max, styrketestene, og evt. gynekologisk undersøkelse). Vi kan 
eventuelt også informere om eventuelle andre helseproblemer vi måtte påvise ved de 
undersøkelsene du gjennomgår. Dette vil foregå ved studiemedarbeiderne (kroppssammensetning, 
VO2 max, styrketestene) eller lege (gynekologisk undersøkelse, beintetthet, evt. andre forhold). 
Olympiatoppen, trenere eller andre vil ikke på noe tidspunkt få tilgang til informasjon om 
enkeltpersoner utover resultater fra de fysiske testene Olympiatoppen får tilgang på slik de gjør 
ved tilsvarende rutinetesting av utøvere.  
 
Studien er vurdert og godkjent av Regional komité for medisinsk forskningsetikk, Midt-Norge og 
vil bli gjennomført etter de regler og retningslinjer som er nedfelt i Helsinkideklarasjonen. Når 
studien er avsluttet vil resultatene bli publisert i et engelskspråklig internasjonalt medisinsk 
tidsskrift.  
 
Frivillig deltakelse  
Studien er frivillig, du kan på hvilken som helst tidspunkt trekke deg uten nærmere begrunnelse 
eller uten at det får noen negative konsekvenser for deg. Dette gjelder selvfølgelig også videre 
oppfølging fra Olympiatoppen. Dersom du trekker deg fra studien har du rett til innsyn i data 
registrert om deg. Du kan også trekke tilbake samtykket. Da vil alle innsamlede opplysninger om 
deg bli slettet og frosne blodprøver vil bli destruert med mindre opplysningene allerede er inngått 
i analyser eller brukt i vitenskaplige publikasjoner.  
Vi ber også om tillatelse til eventuelt å kontakte deg senere for oppfølgning. Dette er kun en 
forespørsel om vi får lov å ta kontakt med deg senere og ikke noe løfte fra deg om at du vil stille 
opp. Dette er ingen forutsetning for å delta i studien. Hvis du samtykker i å delta i studien må du 
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undertegne en samtykkeerklæring lik den som er vedlagt før du deltar. Personopplysninger som 
knytter deg til data vil bli oppbevart til utgangen av 2014 og deretter slettet.  
 
Personvern  
Opplysninger som registreres om deg er:  
 Helseopplysninger som du selv gir oss  
 Opplysninger om din aktuelle medisinbruk  
 Resultater av blodprøveanalyser som tas  
 Opplysninger om de tester og undersøkelser du gjennomgår  
 Svar på de spørreskjema du besvarer  
 Enkle kliniske data (høyde, vekt, blodtrykk etc.)  
 
Opplysningene legges inn i en database ved Enhet for anvendt klinisk forskning, NTNU i 
avidentifisert form, dvs. ikke med ditt navn eller fødselsnummer men kun med ditt 
deltagernummer.  
Alt personell som er involvert i studien og behandlingen av innsamlede data har taushetsplikt.  
Representanter for kontrollmyndigheter kan få utlevert studieopplysninger og gis innsyn i 
relevante deler av din journal. Dette er lovpålagt. Formålet er å kontrollere at studieopplysningene 
stemmer overens med tilsvarende opplysninger i din journal. Alle som får innsyn i informasjon 
om deg har taushetsplikt.  
 
Forskningsbiobank  
Blodprøvene som blir tatt og informasjonen utledet av dette materialet vil bli lagret i en 
forskningsbiobank som professor Sven M. Carlsen er ansvarlig for. De vil bli lagret i ikke 
personidentifiserbar stand, dvs. bare identifisert med deltagernummer.  
 
Utlevering av materiale og opplysninger til andre  
Hvis du sier ja til å delta i studien, gir du også ditt samtykke til at prøver og avidentifiserte 
opplysninger kan utleveres til våre samarbeidspartnere i forskning.  
 
Innsynsrett og oppbevaring av materiale  
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som er registrert 
om deg. Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. 
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Dersom du trekker deg fra studien, vil det ikke samles inn flere opplysninger eller mer materiale. 
Opplysninger som allerede er innsamlet fra deg vil ikke bli slettet.  
 
Finansiering  
Studien og biobanken er søkt finansiert av forskningsmidler fra Olympiatoppen og 
forskningsmidler som professor Sven M. Carlsen har innestående ved Unimed Innovation. 
Sponsor (ansvarlig myndighet for studien) er Institutt for kreftforskning og molekylærmedisin, 
NTNU.  
 
Forsikring  
Du er forsikret gjennom Pasientskadeerstatningsordningen.  
Med vennlig hilsen  
_________________________  
Sven M. Carlsen  
Professor dr. med. Prosjektleder  
 
Prosjektledelse:  
Prosjektleder og medisinsk ansvarlig: Sven M. Carlsen, professor, spesialist i indremedisin og 
endokrinologi,  
Enhet for anvendt klinisk forskning, NTNU og Avdeling for endokrinologi, St. Olavs hospital 
Email: sven.carlsen@ntnu.no, Tlf: 73550263, Mobil: 91769528 
 
Veileder og forskningsmedarbeider: Kirsten Rasmussen, professor, Fakultet for 
samfunnsvitenskap og teknologiledelse, Psykologisk institutt, NTNU Email: 
kirsten.rasmussen@svt.ntnu.no, Tlf: 73597833  
 
Veileder og forskningsmedarbeider: Liv Berit Augestad, professor, Fakultet for 
samfunnsvitenskap og teknologiledelse, Institutt for Bevegelsesvitenskap, NTNU Email: 
liv.berit.augestad@svt.ntnu.no, Tlf: 73591771  
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Prosjektmedarbeider, Øyvind Sandbakk, Ph.D, Senter for toppidrettsforskning, Fakultet for 
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Appendix 2 – Declaration of Consent 
 
SAMTYKKEERKLÆRING 
 
For deltakeren:  
Jeg bekrefter med dette at jeg har fått den informasjon jeg ønsker om og er villig til å delta i 
”The Female Competitiveness Study”. Jeg vet at jeg uten nærmere begrunnelse kan trekke 
med fra studien på et hvert tidspunkt dersom jeg skulle ønske det uten at det vil ha 
konsekvenser for meg. Jeg er klar over at de innsamlede data brukes utelukkende til forskning 
og eventuell egen nytte ved økt kunnskap om meg selv. 
 
Jeg samtykker i å delta i prosjektet som innebærer følgende: 
- Testing av fysisk kapasitet (maksimal muskelkraft og VO2max) 
- Dexa-scan av kroppssammensetning  
- Blodprøvetaking for hormonanalyser  
- Spørreskjema angående konkurranseinstinkt, spenningssøking, spisevaner, mental 
helse og seksuell orientering 
- Gynekologisk undersøkelse (ingen betingelse for å delta i resten av studien) 
- Enkel klinisk undersøkelse (høyde, vekt, blodtrykk etc.) 
- Fotokopi av hendene 
 
Dersom du godkjenner at vi kontakter deg for eventuell oppfølgende forskning på et senere 
tidspunkt, vennligst kryss av her:       
 
Dersom du ønsker å bli kontaktet dersom blodprøver eller andre av undersøkelsene gir 
mistanke om spesielle medisinske problemer hos deg, vennligst kryss av her:   
 
 
Sted:___________________________             Dato:___/___- 2011 
 
Navn:__________________________________________________ 
         (Deltakers fulle navn med BLOKKBOKSTAVER) 
 
                                  ______________________________________ 
                                                    Deltagers underskrift 
 
Jeg bekrefter med dette at deltageren har fått muntlig og skriftlig informasjon om studien, har 
fått svar på de muntlige spørsmål hun hadde og har underskrevet på denne 
deltagerformasjonen: 
 
Sted: __________________________               Dato:___/___- 2011 
 
Studiemedarbeider: ___________________________________________  
 
Ansvarlige lege for undersøkelsen:Sven M. Carlsen, Professor, Enhet for anvendt klinisk 
forskning, NTNU, Overlege, Avdeling for endokrinologi, St. Olavs hospital 
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Appendix 3 – Approval from the Regional Ethics Committee 
 
Below is the approval from Regional Ethics Committee, Mid-Norway, recieved October 
2011. 
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Appendix 4 – Pearson Correlation Analyses 
Below is the Pearson correlations analysis of total group, showing how the hormones 
covariates with body composition and physical performance, and how the different body 
composition variables covariate with each other. The statistically significant values are 
marked by ** and with red colour. 
 
 
Pearson correlations of stratified group below show how the hormones correlate with body 
composition and physical performance, and how the different body composition variables 
covariate with each other.  
  
 
Age BMI Lean total Fat total % 
Squat Jump 
height cm LastMINVO2 Gruppe12 
Age Pearson Correlation 1 -,004 ,184 -,246 ,116 -,113 ,003 
Sig. (2-tailed)  ,984 ,315 ,175 ,513 ,532 ,985 
BMI Pearson Correlation -,004 1 ,625** ,640** ,125 -,412* -,440** 
Sig. (2-tailed) ,984  ,000 ,000 ,482 ,017 ,009 
Lean total Pearson Correlation ,184 ,625** 1 ,050 ,134 -,080 -,087 
Sig. (2-tailed) ,315 ,000  ,785 ,463 ,670 ,635 
Fat total % Pearson Correlation -,246 ,640** ,050 1 -,079 -,631** -,617** 
Sig. (2-tailed) ,175 ,000 ,785  ,669 ,000 ,000 
17_OH-progesteron 
(nmol/L) 
Pearson Correlation -,051 ,438* ,413* ,316 ,007 -,367* -,301 
Sig. (2-tailed) ,780 ,012 ,019 ,078 ,968 ,043 ,094 
Testosteron (nmol/L) Pearson Correlation -,071 ,262 ,325 ,246 -,052 -,286 -,215 
Sig. (2-tailed) ,698 ,148 ,069 ,175 ,777 ,119 ,238 
SHBG (nmol/L) Pearson Correlation -,230 ,004 -,232 ,177 ,069 ,227 ,059 
Sig. (2-tailed) ,205 ,982 ,202 ,333 ,709 ,218 ,748 
Androstendion (nmol/L) Pearson Correlation ,057 ,059 ,330 ,035 ,000 -,259 -,144 
Sig. (2-tailed) ,756 ,747 ,065 ,851 ,999 ,159 ,433 
DHEAS (mikromol/L) Pearson Correlation -,131 ,372* ,431* ,163 ,208 -,186 -,273 
Sig. (2-tailed) ,476 ,036 ,014 ,373 ,253 ,317 ,131 
FTI (testosteron * 
10/SHBG) 
Pearson Correlation ,094 ,135 ,325 ,094 ,072 -,321 -,245 
Sig. (2-tailed) ,608 ,461 ,070 ,610 ,695 ,079 ,177 
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Sport Age BMI Lean total Fat total % 
Squat Jump 
height cm LastMIN VO2 
Soccer Age Pearson Correlation 1 -,024 ,132 -,346 ,203 -,246 
Sig. (2-tailed)  ,908 ,548 ,106 ,329 ,246 
BMI Pearson Correlation -,024 1 ,728** ,547** -,031 -,074 
Sig. (2-tailed) ,908  ,000 ,007 ,883 ,732 
Lean total Pearson Correlation ,132 ,728** 1 ,137 ,176 -,032 
Sig. (2-tailed) ,548 ,000  ,533 ,422 ,887 
Fat total % Pearson Correlation -,346 ,547** ,137 1 -,502* -,257 
Sig. (2-tailed) ,106 ,007 ,533  ,015 ,248 
17_OH-progesteron 
(nmol/L) 
Pearson Correlation ,033 ,391 ,553** ,217 -,128 -,210 
Sig. (2-tailed) ,882 ,065 ,006 ,320 ,560 ,347 
Testosteron (nmol/L) Pearson Correlation -,204 ,220 ,257 ,325 -,107 -,186 
Sig. (2-tailed) ,350 ,313 ,237 ,131 ,628 ,407 
SHBG (nmol/L) Pearson Correlation -,265 -,016 -,267 ,229 ,138 ,344 
Sig. (2-tailed) ,222 ,943 ,219 ,293 ,531 ,117 
Androstendion 
(nmol/L) 
Pearson Correlation -,014 -,003 ,300 ,086 ,061 -,301 
Sig. (2-tailed) ,949 ,990 ,164 ,695 ,783 ,173 
DHEAS 
(mikromol/L) 
Pearson Correlation -,140 ,340 ,438* ,134 ,254 -,001 
Sig. (2-tailed) ,524 ,112 ,037 ,541 ,243 ,997 
FTI (testosteron * 
10/SHBG) 
Pearson Correlation ,078 ,063 ,318 ,003 ,029 -,220 
Sig. (2-tailed) ,724 ,776 ,139 ,991 ,894 ,324 
Cross-
country 
skiing 
Age Pearson Correlation 1 ,165 ,453 -,084 -,220 ,119 
Sig. (2-tailed)  ,671 ,221 ,831 ,570 ,760 
BMI Pearson Correlation ,165 1 ,215 ,368 ,427 -,462 
Sig. (2-tailed) ,671  ,579 ,330 ,252 ,211 
Lean total Pearson Correlation ,453 ,215 1 -,588 -,112 -,147 
Sig. (2-tailed) ,221 ,579  ,096 ,774 ,707 
Fat total % Pearson Correlation -,084 ,368 -,588 1 ,352 -,447 
Sig. (2-tailed) ,831 ,330 ,096  ,353 ,228 
17_OH-progesteron 
(nmol/L) 
Pearson Correlation -,464 ,085 -,355 -,014 ,158 -,161 
Sig. (2-tailed) ,208 ,828 ,348 ,972 ,685 ,680 
Testosteron (nmol/L) Pearson Correlation ,511 ,016 ,565 -,485 -,127 -,128 
Sig. (2-tailed) ,160 ,968 ,113 ,186 ,744 ,743 
SHBG (nmol/L) Pearson Correlation -,035 ,485 ,003 ,507 -,159 -,044 
Sig. (2-tailed) ,928 ,186 ,994 ,163 ,682 ,911 
Androstendion 
(nmol/L) 
Pearson Correlation ,345 -,029 ,414 -,558 -,328 ,068 
Sig. (2-tailed) ,364 ,940 ,268 ,118 ,388 ,862 
DHEAS 
(mikromol/L) 
Pearson Correlation -,067 -,127 ,357 -,696* -,315 ,206 
Sig. (2-tailed) ,864 ,746 ,346 ,037 ,409 ,595 
FTI (testosteron * 
10/SHBG) 
Pearson Correlation ,299 -,354 ,313 -,574 -,088 ,004 
Sig. (2-tailed) ,435 ,350 ,412 ,106 ,822 ,992 
33 
 
 
  
Appendix 5 – Multivariate Regression Analyses 
 
The two first regression analyses are Squat jump height (cm), adjusted for all androgens, body composition 
and age, for total and stratified sample. 
Coefficientsa 
 
Unstandardized Coefficients Standardized Coefficients 
t Sig. B Std. Error Beta 
 (Constant) 37,007 14,543  2,545 ,018 
Age ,116 ,272 ,087 ,426 ,674 
Lean body mass total 6,767E-5 ,000 ,064 ,301 ,766 
Fat % total body -,488 ,335 -,356 -1,457 ,158 
Androstendion (nmol/L) -,257 ,488 -,154 -,526 ,604 
DHEAS (mikromol/L) ,674 ,734 ,229 ,918 ,368 
FTI -1,837 14,086 -,041 -,130 ,897 
Sport discpline -4,555 2,578 -,433 -1,767 ,090 
a. Dependent Variable: Squat Jump height (cm) 
 
 
 
Coefficientsa 
Sport Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
Cross-country  (Constant) 2,800 58,848  ,048 ,966 
Age -,943 1,229 -,609 -,767 ,523 
Lean body mass total ,001 ,001 ,558 ,728 ,542 
Fat % total body 1,056 1,513 ,600 ,698 ,558 
Androstendion (nmol/L) -,523 1,817 -,332 -,288 ,800 
DHEAS (mikromol/L) -2,094 4,885 -,513 -,429 ,710 
FTI 68,865 72,871 ,894 ,945 ,444 
Soccer  (Constant) 32,036 12,634  2,536 ,022 
Age ,159 ,261 ,129 ,609 ,551 
Lean body mass total ,000 ,000 ,112 ,510 ,617 
Fat % total body -,919 ,342 -,551 -2,688 ,016 
Androstendion (nmol/L) ,420 ,520 ,254 ,807 ,431 
DHEAS (mikromol/L) 1,172 ,674 ,424 1,739 ,101 
FTI -17,689 13,775 -,437 -1,284 ,217 
a. Dependent Variable: Squat Jump height (cm) 
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These regression analyses show Last Minute VO2, adjusted for all androgens, body 
composition and age, for total and stratified sample. 
 
 
Coefficientsa 
Sport  
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
Cross-country  (Constant) 110,177 12,478  8,830 ,013 
Age ,952 ,261 ,930 3,652 ,067 
Lean body mass total -,001 ,000 -1,144 -4,659 ,043 
Fat % total body -1,456 ,321 -1,251 -4,536 ,045 
Androstendion (nmol/L) -,299 ,385 -,286 -,776 ,519 
DHEAS (mikromol/L) 1,720 1,036 ,637 1,660 ,239 
FTI -43,669 15,451 -,857 -2,826 ,106 
Soccer  (Constant) 68,785 11,521  5,970 ,000 
Age -,374 ,227 -,401 -1,645 ,121 
Lean body mass total ,000 ,000 ,164 ,648 ,527 
Fat % total body -,464 ,306 -,355 -1,518 ,150 
Androstendion (nmol/L) -,449 ,460 -,352 -,976 ,344 
DHEAS (mikromol/L) ,173 ,601 ,081 ,287 ,778 
FTI -,322 12,071 -,010 -,027 ,979 
a. Dependent Variable: Last Minute VO2 
 
 
  
Coefficientsa 
 
Unstandardized Coefficients Standardized Coefficients 
t Sig. B Std. Error Beta 
 (Constant)  60,978 10,801  5,646 ,000 
Age -,250 ,194 -,158 -1,293 ,209 
Lean body mass total 3,713E-5 ,000 ,029 ,224 ,825 
Fat % total body -,474 ,245 -,283 -1,936 ,065 
Androstendion (nmol/L) -,263 ,351 -,132 -,750 ,461 
DHEAS (mikromol/L) ,313 ,540 ,088 ,580 ,568 
FTI -3,794 10,159 -,071 -,373 ,712 
Sport discipline 7,645 1,836 ,612 4,164 <,000 
a. Dependent Variable: Last Minute VO2 
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The two last tables show the multivariate regression analyses of fat percentage, adjusted for 
age, androgens, LBM and sport discipline, for total and stratified sample.  
 
Coefficientsa 
 
Unstandardized Coefficients Standardized Coefficients 
t Sig. B Std. Error Beta 
 (Constant) 28,878 6,480  4,456 ,000 
Age -,244 ,155 -,251 -1,573 ,128 
Lean body mass total 6,067E-5 ,000 ,079 ,454 ,654 
Androstendion (nmol/L) -,052 ,291 -,043 -,178 ,860 
DHEAS (mikromol/L) -,120 ,438 -,056 -,274 ,786 
FTI ,117 8,407 ,004 ,014 ,989 
Sport discipline -4,789 1,205 -,625 -3,975 ,001 
a. Dependent Variable: Fat % total body 
 
 
 
Coefficientsa 
Sport  
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
Cross-country  (Constant) 32,521 12,310  2,642 ,078 
Age ,103 ,465 ,117 ,221 ,840 
Lean body mass total ,000 ,000 -,462 -1,051 ,371 
Androstendion (nmol/L) ,157 ,687 ,175 ,229 ,834 
DHEAS (mikromol/L) -1,075 1,757 -,463 -,612 ,584 
FTI -12,124 26,906 -,277 -,451 ,683 
Soccer  (Constant) 20,386 7,475  2,727 ,014 
Age -,260 ,174 -,351 -1,491 ,154 
Lean body mass total ,000 ,000 ,177 ,690 ,500 
Androstendion (nmol/L) ,132 ,368 ,134 ,360 ,723 
DHEAS (mikromol/L) ,053 ,478 ,032 ,112 ,912 
FTI -3,608 9,732 -,149 -,371 ,715 
a. Dependent Variable: Fat % total body 
 
 
 
